Candidate gene polymorphisms in cardiovascular disease: A comparative study of frequencies between a French and an Italian population

Clinical Chemistry and Laboratory Medicine

Volumn 39, Issue 2, 2001, Pages 146-154

  Pallaud, C ^a   Stranieri, C ^a   Sass, C ^a   Siest, G ^a   Pignatti, F ^a   Visvikis, S ^a  

^a INSERM   (France)

Author keywords

Cardiovascular disease; Comparative study; Frequencies; Gene polymorphism

Indexed keywords

ADENINE; ANGIOTENSIN; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; ARGININE; ARYLDIALKYLPHOSPHATASE; ASPARAGINE; BLOOD CLOTTING FACTOR 5; CHOLESTEROL ESTER TRANSFER PROTEIN; CYSTATHIONINE BETA SYNTHASE; CYTOSINE; DNA; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; GLUTAMINE; GLYCOPROTEIN IIIA; GUANINE; HOMOCYSTEINE; LIPOPROTEIN LIPASE; METHYLENETETRAHYDROFOLIC ACID; PHENYLALANINE; RENIN; SERINE; THREONINE; THYMINE; VALINE;

ADULT; ARTICLE; ASSAY; BLOOD VISCOSITY; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; EUROPE; FEMALE; FRANCE; GENE; GENE FREQUENCY; GENOTYPE; HEALTH STATUS; HUMAN; ITALY; LEUKOCYTE ADHERENCE; LIPID METABOLISM; MALE; POPULATION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; THROMBOCYTE AGGREGATION;

ALLELES; BLOOD VISCOSITY; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; FRANCE; GENE FREQUENCY; HOMOCYSTEINE; HUMANS; ITALY; LEUKOCYTES; LIPID METABOLISM; LIPIDS; MALE; PLATELET AGGREGATION; POLYMORPHISM, GENETIC; RENIN-ANGIOTENSIN SYSTEM;

EID: 0035052678     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2001.025     Document Type: Article

References (61)

1. Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: The Stanislas cohort
2. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal
3. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease
4. Combined effects of lipoprotein lipase and apolipoprotein E polymorphisms on lipid and lipoprotein levels in the Stanislas cohort
5. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
6. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease
7. Rapid detection of the hypertension-associated Met235← Thr allele of the human angiotensinogen gene
8. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease
9. Mutation in blood coagulation factor V associated with resistance to activated protein C
10. The molecular basis of homocystinuria due to cystathionine beta-synthase deficiency in Italian families, and report of four novel mutations
11. A multilocus genotyping assay for candidate markers of cardiovascular disease risk
12. Hyperlipidaemia associated with genetic variation in the apolipoprotein B gene
13. A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins
14. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency
15. A common variant in the gene for lipoprotein lipase (Asp9→Asn). Functional implications and prevalence in normal and hyperlipidemic subjects
16. A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity
17. LPL promoter -93T/G transition influences fasting and postprandial plasma triglycerides response in African-Americans and Hispanics
18. Factor V Leiden and risks of recurrent idiopathic venous thromboembolism
19. Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia
20. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms
21. DNA polymorphisms in adhesion molecule genes - A new risk factor for early atherosclerosis
22. Apolipoprotein B gene polymorphisms, lipoproteins and coronary atherosclerosis: A study of young myocardial infarction survivors and healthy population-based individuals
23. Lipoprotein(a) and the significance of the association between platelet glycoprotein IIIa polymorphisms and the risk of premature myocardial infarction
24. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations
25. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden
26. Apolipoprotein B polymorphism and altered apolipoprotein B and low density lipoprotein cholesterol concentrations in Finnish children
27. The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis
28. Opposite effects of plasma homocysteine and the methylenetetrahydrofolate reductase C677T mutation on carotid artery geometry in asymptomatic adults
29. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine and other risk factors for vascular disease
30. Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects
31. The genotype interactions of methylenetetrahydrofolate reductase and renin-angiotensin system genes are associated with myocardial infarction
32. C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): Its frequency and impact on plasma homocysteine concentration in different European populations
33. Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients
34. E-selectin polymorphism and atherosclerosis: An association study
35. Relationship of polymorphisms in the renin-angiotensin system and in E-selectin of patients with early severe coronary heart disease
36. Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia
37. Gender related association between genetic variations of APOC-III gene and lipid and lipoprotein variables in northern France
38. ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests
39. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses
40. Variation at the lipoprotein lipase and apolipoprotein AI-CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: Interaction between genotype, gender, and smoking status
41. Association between genetic variation at the APO AI-CIII-AIV gene cluster and familial combined hyperlipidaemia
42. A variation in the apolipoprotein C-III gene is associated with an increased number of circulating VLDL and IDL particles in familial combined hyperlipidemia
43. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations
44. Lipoprotein lipase genotypes for a common premature termination codon mutation detected by PCR-mediated site-directed mutagenesis and restriction digestion
45. Ser447stop mutation in lipoprotein lipase is associated with elevated HDL cholesterol levels in normolipidemic males
46. Lipoprotein lipase gene polymorphisms: Associations with myocardial infarction and lipoprotein levels, the ECTIM study
47. Interaction of the lipoprotein lipase asparagine 291→serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: A study in hyperlipidemic subjects, myocardial infarction adults
48. The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns
49. Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia
50. Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins
51. The Gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients
52. The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study
53. DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population
54. Association between deletion polymorphism of the angiotensin-converting enzyme gene and cerebral atherosclerosis
55. A population study of ethnic variations in the angiotensin-converting enzyme I/D polymorphism: Relationships with gender, hypertension and impaired glucose metabolism
56. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension
57. P1A1/A2 polymorphism of platelet glycoprotein IIIa and risk of acute coronary syndromes in heterozygous familial hypercholesterolemia
58. Platelet glycoprotein IIb/IIIa genetic polymorphism is associated with plasma fibrinogen levels in myocardial infarction patients
59. The Leu33/Pro polymorphism (PIA1/PIA2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study. Etude Cas-Temoins de l'Infarctus du Myocarde
60. European atherosclerosis research study: Genotype at the fibrinogen locus (G-455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence gender-genotype-environment interaction
61. Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort